Approval · Notice of Compliance 17860 · 2016
GLUDEF: Notice of Compliance 17860
Issued March 1, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17860
- Date
- March 1, 2016
- Company
- Isologic Innovative Radiopharmaceuticals Ltd.Dorval, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLUDEF | Not yet assigned | — |
Medicinal ingredients
- FLUDEOXYGLUCOSE 18F 51,500 MBQ per 5ML
- FLUDEOXYGLUCOSE 18F 232,000 MBQ per 20ML